13FPulse
CO

COLL COLLEGIUM PHARMACEUTICAL INC

2026Q2 · CUSIP 19459J104 · Sector: Healthcare & Biotech

Normal

Fund flows are within the usual range

Funds that own it
271
Institutions that reported holding it to the SEC
Net increase in holders
+6
Last quarter 265 → now 271
How unusual is that
Above average
Stronger buying than 59% of US stocks
What the filings say, in one paragraph

271 funds held COLL at the end of 2026Q2, up 6 from the quarter before. Fund flows are within the usual range — nothing unusual. On the business itself, revenue over the last 12 months was $808M(YoY +14.3%), the P/E is 19.8x, return on equity is 15.4%. COLL has had 13 buying rushes in its history, and the price moved +0.0% on average over the six months after (that is the raw price move, not how much it beat the market by). It sits in the Healthcare & Biotech sector.

How many funds owned it, quarter by quarter

Bars = net change in institutional holders, positive (green) or negative (red). Line = total institutional holders.

2015Q3: holders=49 2015Q4: holders=60 2016Q1: holders=71 2016Q2: holders=74 2016Q3: holders=72 2016Q4: holders=87 2017Q1: holders=83 2017Q2: holders=71 2017Q3: holders=74 2017Q4: holders=101 2018Q1: holders=140 2018Q2: holders=135 2018Q3: holders=124 2018Q4: holders=120 2019Q1: holders=144 2019Q2: holders=125 2019Q3: holders=116 2019Q4: holders=137 2020Q1: holders=158 2020Q2: holders=151 2020Q3: holders=141 2020Q4: holders=139 2021Q1: holders=162 2021Q2: holders=159 2021Q3: holders=154 2021Q4: holders=160 2022Q1: holders=171 2022Q2: holders=158 2022Q3: holders=168 2022Q4: holders=179 2023Q1: holders=197 2023Q2: holders=180 2023Q3: holders=175 2023Q4: holders=193 2024Q1: holders=229 2024Q2: holders=228 2024Q3: holders=249 2024Q4: holders=238 2025Q1: holders=242 2025Q2: holders=223 2025Q3: holders=243 2025Q4: holders=277 2026Q1: holders=265 2026Q2: holders=271 -39 -19.5 +0 +19.5 +39 44168291 15Q316Q418Q119Q220Q321Q423Q124Q225Q326Q2 Net change in holders (bars) Total funds holding (line)

What happened after each past buying rush 13 times in its history

Quarter of the rush How unusual then Price, next 3 months Price, next 6 months
2025Q4 Top 20% -24.3%
2025Q3 Top 20% -0.4% -24.5%
2024Q3 Top 20% -0.3% -1.4%
2024Q1 Top 10% +11.1% -8.9%
2023Q1 Top 10% +2.5% +9.3%
2022Q3 Top 20% +29.5% +10.9%
2022Q1 Top 20% +17.0% +36.1%
2021Q1 Top 20% -12.3% -14.6%

These are the raw price moves, not how much it beat the market by. Compare them against the market over the same months — in a strong bull market almost everything is up.

Show all the numbers (large funds, value held, options…) ▾
Of them, large funds
145
Change in large funds
+11
Total value they hold
$1.8B
Funds buying for the first time
45
Funds that sold out entirely
39
Price change that quarter
-26.9%
Funds holding puts (bearish)
2
Funds holding calls (bullish)
2

These are for people who want to dig. Skip them if they do not mean anything to you — the three numbers above are enough.

8,697 institutions have filed for this quarter. 13F permits late filing and a small number arrive in the weeks after the deadline, so the holder counts and changes below may tick up.

Fundamentals

PE (TTM)
19.8
EPS (TTM)
$1.24
EPS YoY
+19.2%
Revenue (TTM)
$0.8B
Revenue YoY
+14.3%
Net margin
5.9%
ROE
15.4%
Debt ratio
85.4%
FCF (TTM)
$328M
Dividend (TTM)
No dividend
Quarterly Revenue & EPS
2021-09-30: EPS 0.22 2021-12-31: EPS -0.73 2022-03-31: EPS -0.39 2022-06-30: EPS -0.15 2022-09-30: EPS 0.01 2022-12-31: EPS -0.21 2023-03-31: EPS -0.51 2023-06-30: EPS 0.34 2023-09-30: EPS 0.53 2023-12-31: EPS 0.82 2024-03-31: EPS 0.71 2024-06-30: EPS 0.52 2024-09-30: EPS 0.27 2024-12-31: EPS 0.36 2025-03-31: EPS 0.07 2025-06-30: EPS 0.34 2025-09-30: EPS 0.84 2025-12-31: EPS 0.46 2026-03-31: EPS 0.40 2026-06-30: EPS -0.46 0M 105M 209M $M -0.80 0.06 0.92 201720182019202020212022202320242025202606/26 Revenue EPS

Quarterly figures, revenue up to 10 years back; EPS split-adjusted, early quarters hidden when not calibrable

P/E (TTM) over time
4Y median 25 11 94 176 2023202420252026

P/E = close around day 47 after quarter-end ÷ TTM EPS then; this is a consistent valuation date, not the company’s actual filing date; loss quarters hidden

Quarterly free cash flow
-25M48M122M 20162017201820192020202120222023202420252026
Latest quarter $57M (2026-03-31)

FCF = operating cash flow − capex, computed from SEC XBRL; banks/insurers have no standard cash-flow structure and are hidden

As of 2026-06-30 · SEC filings (XBRL)

Email me the next update

2026 Q3 holdings are due 2026-11-16. We will email you when the refreshed lists are live.